Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lewis J Rubin & Nicholas W Morrell. (2011) New frontiers in pulmonary hypertension. Expert Review of Respiratory Medicine 5:2, pages 139-140.
Read now
Read now
Articles from other publishers (34)
Joud Enabi, Maha Tahir, Srikanth Mukkera & Alejandra Garcia Fernandez. (2023) A Rare Presentation of Systemic Sclerosis. Cureus.
Crossref
Crossref
Na Zhang, Shizhou Liu, Zhaoliang Zhang, Ying Liu, Liangyu Mi & Ke Xu. (2023) Lung Transplantation: A Viable Option for Connective Tissue Disease?. Arthritis Care & Research 75:11, pages 2389-2398.
Crossref
Crossref
Olivier Boucherat, Vineet AgrawalAllan Lawrie & Sebastien Bonnet. (2022) The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure. Circulation Research 130:9, pages 1466-1486.
Crossref
Crossref
Nirmal Parajuli & Djuro Kosanovic. (2022) Editorial: Oxidative Stress in Cardiovascular Diseases and Pulmonary Hypertension. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Loukianos Rallidis, Konstantina Papangelopoulou, Georgios Makavos, Christos Varounis, Anastasia Anthi & Stylianos Orfanos. (2021) Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension. Journal of Clinical Medicine 10:17, pages 3972.
Crossref
Crossref
Loukianos S. Rallidis, Konstantina Papangelopoulou, Anastasia Anthi, Iraklis Tsangaris, Christos Varounis, Georgios Makavos, Dimitrios Konstantonis, Panagiotis Vlachoyiannopoulos, Stylianos E. Orfanos & Efstathios K. Iliodromitis. (2021) The Role of Exercise Doppler Echocardiography to Unmask Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis and Equivocal Baseline Echocardiographic Values for Pulmonary Hypertension. Diagnostics 11:7, pages 1200.
Crossref
Crossref
T. Semalulu, L. Rudski, T. Huynh, D. Langleben, M. Wang, M.J. Fritzler, J. Pope, M. Baron & M. Hudson. (2020) An evidence-based strategy to screen for pulmonary arterial hypertension in systemic sclerosis. Seminars in Arthritis and Rheumatism 50:6, pages 1421-1427.
Crossref
Crossref
Panagiota Xanthouli, Suzana Jordan, Nicklas Milde, Alberto Marra, Norbert Blank, Benjamin Egenlauf, Matthias Gorenflo, Satenik Harutyunova, Hanns-Martin Lorenz, Christian Nagel, Vivienne Theobald, Mona Lichtblau, Charlotte Berlier, Silvia Ulrich, Ekkehard Grünig, Nicola Benjamin & Oliver Distler. (2020) Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension. Annals of the Rheumatic Diseases 79:3, pages 370-378.
Crossref
Crossref
Yannick Allanore, Farhad Gharibdoost, Ahmad Reza Jamshidi, Ali Javinani, Jérôme Avouac, Elnaz Rastkar, Sadid Hooshmandi & Hoda Kavosi. (2018) Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers. Journal of Scleroderma and Related Disorders 4:2, pages 149-159.
Crossref
Crossref
Andreas J. Rieth, Manuel J. Richter, Alexander Berkowitsch, Marc Frerix, Ingo H. Tarner, Veselin Mitrovic & Christian W. Hamm. (2018) Intravenous sildenafil acutely improves hemodynamic response to exercise in patients with connective tissue disease. PLOS ONE 13:9, pages e0203947.
Crossref
Crossref
Zariel I. Johnson, Jacqueline D. Jones, Angana Mukherjee, Dianxu Ren, Carol Feghali-Bostwick, Yvette P. Conley & Cecelia C. Yates. (2018) Novel classification for global gene signature model for predicting severity of systemic sclerosis. PLOS ONE 13:6, pages e0199314.
Crossref
Crossref
Theodoros Karampitsakos, Argyrios Tzouvelekis, Serafeim Chrysikos, Demosthenes Bouros, Iraklis Tsangaris & Wassim H. Fares. (2018) Pulmonary hypertension in patients with interstitial lung disease. Pulmonary Pharmacology & Therapeutics 50, pages 38-46.
Crossref
Crossref
Tracy J. Doyle & Paul F. Dellaripa. (2017) Lung Manifestations in the Rheumatic Diseases. Chest 152:6, pages 1283-1295.
Crossref
Crossref
Philipp Arnold, Anna Otte & Christoph Becker-Pauly. (2017) Meprin metalloproteases: Molecular regulation and function in inflammation and fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864:11, pages 2096-2104.
Crossref
Crossref
Murray Baron. (2017) Pros and Cons of Echocardiography in the Screening, Diagnosis and Follow-up of Patients with Systemic Sclerosis Pulmonary Arterial Hypertension – a Rheumatologist's Perspective. Journal of Scleroderma and Related Disorders 2:2, pages 108-114.
Crossref
Crossref
Carlo Marini, Bruno Formichi, Carolina Bauleo, Claudio Michelassi, Edoardo Airò, Giuseppe Rossi & Carlo Giuntini. (2016) Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension. Internal and Emergency Medicine 11:7, pages 941-952.
Crossref
Crossref
Su-Jin YooJae-Hyeong ParkYunseon ParkJae-Hwan LeeByung-Joo SunJinhyun KimIn Seol YooSeung Cheol ShimSeong Wook Kang. (2016) Prevalence of Pulmonary Arterial Hypertension in Korean Adult Patients with Systemic Sclerosis: Result of a Pilot Echocardiographic Screening Study. Journal of Cardiovascular Ultrasound 24:4, pages 312.
Crossref
Crossref
Li Gao, Mary J. Emond, Tin Louie, Chris Cheadle, Alan E. Berger, Nicholas Rafaels, Candelaria Vergara, Yoonhee Kim, Margaret A. Taub, Ingo Ruczinski, Stephen C. Mathai, Stephen S. Rich, Deborah A. Nickerson, Laura K. Hummers, Michael J. Bamshad, Paul M. Hassoun, Rasika A. Mathias & Kathleen C. Barnes. (2016)
Identification of Rare Variants in
ATP8B4
as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing
. Arthritis & Rheumatology 68:1, pages 191-200.
Crossref
Crossref
Omar A. Minai, Quyen Nguyen, Srinivas Mummadi, Esteban Walker, Kevin McCarthy & Raed A. Dweik. (2015) Heart Rate Recovery is an Important Predictor of Outcomes in Patients with Connective Tissue Disease–Associated Pulmonary Hypertension. Pulmonary Circulation 5:3, pages 565-576.
Crossref
Crossref
Cheng-gui Miao, You-yi Xiong, Hao Yu, Xiao-lin Zhang, Mei-song Qin, Tong-wen Song & Chuan-lai Du. (2015) Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions. International Immunopharmacology 28:1, pages 626-633.
Crossref
Crossref
Eduardo Bossone, Santo Dellegrottaglie, Smita Patel, Ekkehard Grunig, Antonello D'Andrea, Francesco Ferrara, Paola Gargiulo, Michele D'Alto, Andrea Soricelli, Antonio Cittadini, Javier Sanz, Pasquale Perrone-Filardi & Melvyn Rubenfire. (2015) Multimodality Imaging in Pulmonary Hypertension. Canadian Journal of Cardiology 31:4, pages 440-459.
Crossref
Crossref
Stephen C. Mathai, Paul M. Hassoun, Milo A. Puhan, Yi Zhou & Robert A. Wise. (2015) Sex Differences in Response to Tadalafil in Pulmonary Arterial Hypertension. Chest 147:1, pages 188-197.
Crossref
Crossref
Isabel Blanco, Stephen Mathai, Majid Shafiq, Danielle Boyce, Todd M. Kolb, Hala Chami, Laura K. Hummers, Traci Housten, Neal Chaisson, Ari L. Zaiman, Fredrick M. Wigley, Ryan J. Tedford, David A. Kass, Rachel Damico, Reda E. Girgis & Paul M. Hassoun. (2014) Severity of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in African Americans. Medicine 93:5, pages 177-185.
Crossref
Crossref
Rajamma Mathew. (2014) Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity. American Journal of Physiology-Heart and Circulatory Physiology 306:1, pages H15-H25.
Crossref
Crossref
Neal F. Chaisson & Paul M. Hassoun. (2013) Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. Chest 144:4, pages 1346-1356.
Crossref
Crossref
Jolyane Meloche, Sébastien Renard, Steeve Provencher & Sébastien Bonnet. 2013. Pharmacotherapy of Pulmonary Hypertension. Pharmacotherapy of Pulmonary Hypertension
437
476
.
Jose Gomez-Arroyo, Sheinei J. SaleemShiro MizunoAamer A. Syed, Harm J. BogaardAntonio Abbate, Laimute Taraseviciene-Stewart, Yon Sung, Donatas Kraskauskas, Daniela Farkas, Daniel H. ConradMark R. Nicolls & Norbert F. Voelkel. (2012) A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. American Journal of Physiology-Lung Cellular and Molecular Physiology 302:10, pages L977-L991.
Crossref
Crossref
Ekkehard Grünig. (2012) Treatment of Pulmonary Arterial Hypertension in Connective Tissue Disease. Drugs 72:8, pages 1039-1056.
Crossref
Crossref
Ivan M. Robbins, Timothy M. Moore, Carol J. Blaisdell & Steven H. Abman. (2012) Improving Outcomes for Pulmonary Vascular Disease. American Journal of Respiratory and Critical Care Medicine 185:9, pages 1015-1020.
Crossref
Crossref
Ivan M. RobbinsTimothy M. MooreCarol J. BlaisdellSteven H. Abman. (2012) National Heart, Lung, and Blood Institute Workshop. Circulation 125:17, pages 2165-2170.
Crossref
Crossref
Peter J. Leary & Jeffrey D. Edelman. (2012) Screening for Pulmonary Arterial Hypertension. Advances in Pulmonary Hypertension 11:2, pages 78-83.
Crossref
Crossref
Yusuke Fukuda, Shin-ichiro Miura & Keijiro Saku. (2012) CREST Syndrome with Pulmonary Arterial Hypertension. Internal Medicine 51:4, pages 441-442.
Crossref
Crossref
Carmen Cantisani, Carlo Mattozzi, Simona Giancristoforo, Sara D'Epiro & Antonio G. Richetta. (2011) Bosentan treatment of digital ulcers related to autoimmune disorders. Drug Development Research 72:8, pages 750-755.
Crossref
Crossref
STEPHEN C. MATHAI. (2011) The Wisdom of the PHAROS. The Journal of Rheumatology 38:10, pages 2089-2091.
Crossref
Crossref